FTC seeks additional information on MiMedx's acquisition of Sanara MedTech
MDXG•Sanara MedTech and MiMedx received requests for additional information from the FTC on October 15, 2026, extending the merger review. The waiting period will run until 30 days after substantial compliance unless extended by the parties or ended earlier by the FTC.
1. FTC requests information
Sanara MedTech and MiMedx received requests for additional information from the Federal Trade Commission on October 15, 2026, extending their merger review. The waiting period runs until 30 days following substantial compliance, unless the parties voluntarily extend it or the FTC ends it earlier.
2. Acquisition terms
MiMedx would acquire Sanara MedTech as a wholly owned subsidiary. Completion remains subject to the waiting period’s expiration or termination and other closing conditions.
